B. P. Moore

发表

A high-throughput screening strategy to overcome virus instability.

E. White, W. Severson, L. Rasmussen, 2011, Assay and drug development technologies.

(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.

Jennifer E. Golden, Nichole A. Tower, C. Jonsson, 2012, Journal of medicinal chemistry.

A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus

Jennifer E. Golden, C. Jonsson, D. Chung, 2013, Virology Journal.

Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.

D. Welch, J. Hopper, D. Hurst, 2006, Biochemical and biophysical research communications.

Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression

J. Markert, E. Beierle, J. Bernstock, 2018, Scientific Reports.

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts

E. Beierle, Raoud Marayati, B. P. Moore, 2019, Translational oncology.

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

E. Beierle, B. P. Moore, J. Stewart, 2018, Scientific Reports.

UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts

A. Hjelmeland, E. Beierle, L. Nan, 2018, Journal of Neuro-Oncology.

Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.

J. Markert, E. Beierle, G. Gillespie, 2016, Neuro-oncology.

Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

J. Markert, E. Beierle, G. Gillespie, 2017, Molecular therapy oncolytics.

γ134.5-Deleted HSV-1 Expressing Human Cytomegalovirus IRS1 Gene Kills Human Glioblastoma Cells as Efficiently as Wild-type HSV-1 in Normoxia or Hypoxia

J. Markert, E. Beierle, G. Gillespie, 2014, Gene Therapy.

Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).

D. Welch, D. Hurst, M. T. Debies, 2006, Cancer letters.

Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells*

Kedar S Vaidya, M. Accavitti-Loper, D. Welch, 2008, Journal of Biological Chemistry.

Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression

J. Markert, E. Beierle, J. Bernstock, 2018, Scientific Reports.

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

E. Beierle, B. P. Moore, J. Stewart, 2018, Scientific Reports.

γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia

J. Markert, E. Beierle, G. Gillespie, 2015, Gene Therapy.

A Cell Based HTS Approach for the Discovery of New Inhibitors of RSV

Jennifer E. Golden, Nichole A. Tower, C. Jonsson, 2013 .

Identification of a Series of Quinazolinediones as Potent, Selective, Post-Entry Inhibitors of Human Respiratory Syncytial Virus ( h RSV) via a Cell-Based High Throughput Screen and Chemical Optimization

Jennifer E. Golden, Nichole A. Tower, Carrie W. Evans, 2013 .

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts

E. Beierle, Raoud Marayati, B. P. Moore, 2019, Translational oncology.

HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity

Qianjun Li, C. Jonsson, D. Chung, 2010, Molecules.